Congenital Bile Acid Synthesis Defect Type 2
Oncology·MeSH: Mucopolysaccharidosis VI
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Congenital Bile Acid Synthesis Defect Type 2?
There are 1 clinical trial targeting Congenital Bile Acid Synthesis Defect Type 2 tracked by BioSniper.
What is the prevalence of Congenital Bile Acid Synthesis Defect Type 2?
The estimated prevalence of Congenital Bile Acid Synthesis Defect Type 2 is approximately 0.1 per 100,000 population.
Deep-dive into Congenital Bile Acid Synthesis Defect Type 2
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis